QUALITY OF LIFE IN PATIENTS WITH BIPOLAR DISORDER IN 5 EUROPEAN COUNTRIES

Author(s)

Oscar Leeuwenkamp, PhD, Director, Health Economics & Strategic Pricing1, Richard Perry, BSc, Development Director2, Robert Morlock, PhD, Director3, Eddie Jones, BSc, Project Director2, Tom Taylor, PhD, Director41Organon International Inc, Molenstraat, Oss, Netherlands; 2 Adelphi Group Products, Bollington, Cheshire, United Kingdom; 3 Pfizer Inc, New York, NY, USA; 4 Pfizer, Ann Arbor, MI, USA

OBJECTIVES: To provide information on patient-reported quality of life for patients with bipolar disorder in five European countries. METHODS: Physicians in France, Germany, Italy, Spain, and the UK who managed at least ten patients with bipolar disorder within the preceding six months were invited to complete a questionnaire concerning their patients' clinical status and therapy. Patients of these physicians were also invited to complete a questionnaire that included the Euroqol EQ-5D, a 5-item questionnaire assessing quality of life in five key areas: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Patient responses to the 5 EQ-5D items were used to generate EQ-5D utility scores. The patients were also asked to rate their current health on a Visual Analog Scale (EQ-5D VAS). These data were collected in 2005. RESULTS: Data on self-reported quality of life were collected from 1335 patients from France (n=304), Germany (n=247), Italy (n=156), Spain (n=492), and the UK(n=136). Most were outpatients (85%) and most were aged 25–64 (87%); 57% were women. The most commonly reported reason for the physician visit was maintenance (44%), followed by depressed (23%), manic (13%), hypomanic (9%), and mixed (8%) health states. Mean (± standard deviation) EQ-5D utility scores (76.0±26.7) were greater than EQ-5D VAS scores (63.2±20.4). This relationship held across all countries. EQ-5D utility and VAS scores were significantly higher for Germany (P<0.01) and significantly lower for Spain (P<0.05). Patients reporting depressed health state as the reason for their visit had the lowest reported EQ-5D utility (64.2±33.5) and EQ-5D VAS (52.7±21.3) scores. CONCLUSIONS: In this large, multinational, cross-sectional survey of physicians and their patients with bipolar disorder, patient-reported quality of life varied by country and current phase of illness.

Conference/Value in Health Info

2006-10, ISPOR Europe 2006, Copenhagen, Denmark

Value in Health, Vol. 9, No.6 (November/December 2006)

Code

PMH42

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×